2020 annual financial data

Cullinan Therapeutics 2020 Net margin

Cullinan Therapeutics 2020 net margin with verified reported values.

Direct answer

Net margin was -268.43%.

Operating income was -60,335,000 USD and net income was -50,849,000 USD.
Operating cash flow was -29,772,000 USD.

Get free Cullinan Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
18,943,000 USD
Operating income
-60,335,000 USD
Net income
-50,849,000 USD
Operating cash flow
-29,772,000 USD